Private Capital Advisors, Inc. Bluebird Bio, Inc. Transaction History

Private Capital Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 12, 2021	SELL	$11.24 - $21.0 $86,548 - $161,700	-7,700 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$18.04 - $22.09 $138,908 - $170,093	7,700 New	7,700 $246,000
Q3 2019 Oct 15, 2019	SELL	$59.47 - $93.1 $166,516 - $260,679	-2,800 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$75.84 - $105.21 $212,352 - $294,588	2,800 New	2,800 $356,000

146

63.3M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $637M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Private Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Private Capital Advisors, Inc. with notifications on news.